DIG
MDLN

Dragoneer Investment Group’s Medline Inc MDLN Stock Holding History

Dragoneer Investment Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-525,000
Closed -$22.1M – 28
2025
Q4 		$22.1M Buy
+525,000
New +$22.2M 0.48% 21

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Dragoneer Investment Group's MDLN Position: Q1 2026 in Review

Dragoneer Investment Group sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 525,000 shares — an estimated $22.1M sold.

Dragoneer Investment Group first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $22.1M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Dragoneer Investment Group reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
  • Dragoneer Investment Group sold 525,000 Medline Inc shares in Q1 2026, an estimated $22.1M.
  • Dragoneer Investment Group first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
  • Dragoneer Investment Group's Medline Inc position peaked at $22.1M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Dragoneer Investment Group's 13F filing for Q1 2026, filed 15 May 2026.